Clinical Updates
Drug approvals, guideline changes, and treatment advances
University of Queensland Drug Targets Immune Receptor, Offering Hope for Motor Neuron Disease
Researchers at the University of Queensland have developed a novel drug that activates a previously difficult-to-target immune receptor, a breakthrough…
Editor's Top Picks
High benchmark scores mask critical brittleness in health AI systems, Nature Medicine study reveals
A Nature Medicine study reveals that large language models achieve high scores on health AI benchmarks yet fail adversarial stress…
Submit Your Paper →
More form Clinical Updates
Late-life breast cancer screening reveals diagnosis in 79-year-old woman
A 79-year-old woman in the United Kingdom discovered breast cancer after self-initiating a mammography request,…
Rare pelvic tumour safely removed through interdepartmental collaboration at Hungarian teaching hospital
A young woman regained full mobility within 24 hours following laparoscopic removal of a rare…
H. pylori screening yields fivefold return in gastric cancer prevention, health economics analysis shows
Health economics analysis shows each dollar invested in Helicobacter pylori screening generates approximately five dollars…
Cancer drug shortages force US hospitals to ration chemotherapy as supply crisis deepens
US oncology departments face critical shortages of essential generic chemotherapy drugs, forcing some hospitals to…
NHS Expands Access to Pembrolizumab for Advanced Cervical Cancer
The NHS has approved pembrolizumab, an immune checkpoint inhibitor, for hundreds of women with advanced…

